Phase 1/2 study of venetoclax, a BCL-2 inhibitor, in Japanese patients with relapsed or refractory chronic lymphocytic leukemia and small lymphocytic lymphoma
Izutsu, Koji, Yamamoto, Kazuhito, Kato, Koji, Ishikawa, Takayuki, Fukuhara, Noriko, Terui, Yasuhito, Choi, Ilseung, Humphrey, Kathryn, Kim, Su Young, Okubo, Sumiko, Ogawa, Natsumi, Nishimura, Yasuko,Journal:
International Journal of Hematology
DOI:
10.1007/s12185-020-03024-3
Date:
October, 2020
File:
PDF, 944 KB
2020